Trial Profile
A randomized double-blind comparative trial of bicalutamide (Casodex) versus placebo in patients with early prostate cancer
Status:
Active, no longer recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 01 Dec 2005
Price :
$35
*
At a glance
- Drugs Bicalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 01 Dec 2005 New trial record.